Previous studies in autoimmunity have found that HLA-G expression reduced the incidence of acute and chronic heart transplant rejection in humans32 and that a single injection of endogenously produced HLA-G could be used as a tolerogenic molecule in skin transplants in animal models13. The gene discussed is HLA-G; the disease is cardiac transplant.